deltatrials
Unknown OBSERVATIONAL NCT02047058

Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological Characteristics

A Multi-center, Prospective, Observational Study of Analysis of Q Cell Markers in Patients With Newly Diagnosed Primary Glioblastoma (Phase IV)

Sponsor: Capital Medical University

Updated 16 times since 2017 Last updated: Jan 25, 2014 Started: Mar 31, 2014 Primary completion: Dec 31, 2016 Completion: Mar 31, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02047058, this observational or N/A phase trial focuses on Glioblastoma and Malignant Glioma and remains ongoing. Sponsored by Capital Medical University, it has been updated 16 times since 2014, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~May 2017 · 4 months · monthly snapshot~May 2017 – ~Jun 2017 · 31 days · monthly snapshot~Jun 2017 – ~Aug 2017 · 2 months · monthly snapshot~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Sep 2020 · 27 months · monthly snapshot~Sep 2020 – ~Nov 2020 · 2 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshot~Oct 2021 – ~Dec 2021 · 2 months · monthly snapshot~Dec 2021 – ~Jul 2023 · 19 months · monthly snapshot~Jul 2023 – ~Jul 2024 · 12 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshot~Feb 2025 – present · 17 months · monthly snapshot

Change History

16 versions recorded
  1. Feb 2025 — Present [monthly]

    Unknown

  2. Sep 2024 — Feb 2025 [monthly]

    Unknown

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown StatusUnknown

  4. Jul 2023 — Jul 2024 [monthly]

    Unknown Status

  5. Dec 2021 — Jul 2023 [monthly]

    Unknown Status

Show 11 earlier versions
  1. Oct 2021 — Dec 2021 [monthly]

    Unknown Status

  2. Jan 2021 — Oct 2021 [monthly]

    Unknown Status

  3. Nov 2020 — Jan 2021 [monthly]

    Unknown Status

  4. Sep 2020 — Nov 2020 [monthly]

    Unknown Status

  5. Jun 2018 — Sep 2020 [monthly]

    Unknown Status

  6. May 2018 — Jun 2018 [monthly]

    Unknown Status

  7. Apr 2018 — May 2018 [monthly]

    Unknown Status

    Phase: NANone

  8. Aug 2017 — Apr 2018 [monthly]

    Unknown Status NA

  9. Jun 2017 — Aug 2017 [monthly]

    Unknown Status NA

  10. May 2017 — Jun 2017 [monthly]

    Unknown Status NA

    Status: Not Yet RecruitingUnknown Status

  11. Jan 2017 — May 2017 [monthly]

    Not Yet Recruiting NA

    First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Capital Medical University
  • Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
  • First Affiliated Hospital of Fujian Medical University
  • First Hospital of China Medical University
  • Guangzhou First People's Hospital
  • Guangzhou General Hospital of Guangzhou Military Command
  • Huashan Hospital
  • Nanfang Hospital, Southern Medical University
  • Qilu Hospital of Shandong University
  • Second Affiliated Hospital of Guangzhou Medical University
  • Second Affiliated Hospital of Soochow University
  • Shenzhen Second People's Hospital
  • Southern Medical University, China
  • Sun Yat-sen University
  • The First Affiliated Hospital of Nanchang University
  • The First Hospital of Jilin University
  • Tianjin Medical University General Hospital
  • West China Hospital
  • Xi'an Jiaotong University
  • Xiangya Hospital of Central South University
Data source: Nanfang Hospital, Southern Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations